Metronidazole Dosing for Adults
Recommended Doses by Indication
The recommended dose of metronidazole varies significantly by indication, with trichomoniasis requiring 500 mg orally twice daily for 7 days (preferred) or 2 g as a single dose, bacterial vaginosis requiring 500 mg orally twice daily for 7 days, and Clostridioides difficile infection requiring 500 mg orally three times daily for 10 days only when vancomycin or fidaxomicin are unavailable. 1, 2, 3, 4
Trichomoniasis
First-line regimen: Metronidazole 500 mg orally twice daily for 7 days 2, 3
Alternative regimen: Metronidazole 2 g orally as a single dose 2, 3, 4
Critical partner management: Treat all sexual partners simultaneously regardless of symptoms 2, 3
Bacterial Vaginosis
- Metronidazole 500 mg orally twice daily for 7 days 3
- Alternative: Metronidazole gel 0.75%, one full applicator (5 g) intravaginally once daily for 5 days 3
- Important caveat: The 2 g single-dose regimen has lower efficacy for bacterial vaginosis and is not preferred 3
Clostridioides difficile Infection (CDI)
- Metronidazole 500 mg orally three times daily for 10 days 1, 6
- Critical limitation: Use ONLY for non-severe CDI when vancomycin (125 mg four times daily) or fidaxomicin (200 mg twice daily) are unavailable 1, 6
- Metronidazole is inferior to vancomycin for CDI (cure rates 84% vs 97%, p<0.006) and has been downgraded to weak recommendation status 1, 6
- Avoid repeated or prolonged courses due to risk of cumulative and potentially irreversible neurotoxicity 1, 6
Fulminant CDI
- Metronidazole 500 mg intravenously every 8 hours PLUS oral/rectal vancomycin 1
- Metronidazole should never be used as monotherapy for severe or fulminant CDI 6
- IV metronidazole is added because it achieves therapeutic concentrations in inflamed colon, especially when ileus impairs oral vancomycin delivery 1
Amebiasis
- Acute intestinal amebiasis: 750 mg orally three times daily for 5-10 days 4
- Amebic liver abscess: 500-750 mg orally three times daily for 5-10 days 4
Anaerobic Bacterial Infections
- Standard dose: 7.5 mg/kg every 6 hours (approximately 500 mg for a 70 kg adult) 4
- Maximum daily dose: 4 g per 24 hours 4
- Usual duration: 7-10 days, though bone/joint, lower respiratory tract, and endocardium infections may require longer treatment 4
Special Population Adjustments
Pregnancy
- Trichomoniasis in 2nd/3rd trimester: 2 g orally as single dose 2, 3, 4
- Contraindicated in first trimester 3, 4
- For pregnant patients requiring treatment, the one-day course should not be used as it results in higher serum levels that can reach fetal circulation 4
Severe Hepatic Disease
- Administer doses below usual recommendations cautiously 4
- Close monitoring of plasma metronidazole levels and toxicity is recommended 4
- Patients with severe hepatic disease metabolize metronidazole slowly, resulting in accumulation 4
Renal Failure
- No specific dose reduction required in anuric patients 4
- Accumulated metabolites are rapidly removed by dialysis 4
Elderly Patients
- Monitor serum levels as pharmacokinetics may be altered 4
- Adjust dosage accordingly based on monitoring 4
Critical Treatment Considerations
Treatment Duration and Extension
- Most patients respond within 10 days, but some (particularly those on metronidazole for CDI) may have delayed response 1, 6
- If symptoms are improving but not resolved by day 10, consider extending treatment to 14 days 1
- Only 71% of CDI patients respond within 6 days on metronidazole 6
Treatment Failure Management
- For trichomoniasis treatment failure: Re-treat with metronidazole 500 mg twice daily for 7 days 2, 3
- For repeated failure: Metronidazole 2 g once daily for 3-5 days 2, 3
- Always exclude reinfection from untreated partners before assuming true treatment failure 2, 3
Factors Associated with Higher Failure Rates
- Age >60 years 6
- Fever, hypoalbuminemia, or peripheral leukocytosis 6
- ICU admission 6
- Abnormal abdominal CT imaging (for CDI) 6
Common Pitfalls to Avoid
Critical Errors
- Never use metronidazole vaginal gel for trichomoniasis—it achieves <50% efficacy and is only approved for bacterial vaginosis 2, 3
- Never use metronidazole as monotherapy for severe or fulminant CDI 1, 6
- Never skip partner treatment for trichomoniasis, even if asymptomatic 2, 3
- Never prescribe repeated or prolonged courses for CDI due to neurotoxicity risk 1, 6